{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:13:22Z","timestamp":1780488802102,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T00:00:00Z","timestamp":1285113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s10875-010-9452-z","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T08:23:27Z","timestamp":1285057407000},"page":"886-893","source":"Crossref","is-referenced-by-count":44,"title":["Diffuse Large B Cell Lymphoma in Hyper-IgE Syndrome Due To STAT3 Mutation"],"prefix":"10.1007","volume":"30","author":[{"given":"Attila","family":"Kum\u00e1novics","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie L.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa H.","family":"Cessna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy H.","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry R.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,22]]},"reference":[{"key":"9452_CR1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","volume":"340","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections\u2014an autosomal dominant multisystem disorder. N Engl J Med. 1999;340:692\u2013702.","journal-title":"N Engl J Med"},{"key":"9452_CR2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00228.x","volume":"203","author":"B Grimbacher","year":"2005","unstructured":"Grimbacher B, Holland SM, Puck JM. Hyper-IgE syndromes. Immunol Rev. 2005;203:244\u201350.","journal-title":"Immunol Rev"},{"key":"9452_CR3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","volume":"125","author":"C Woellner","year":"2010","unstructured":"Woellner C, Gertz EM, Schaffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125:424\u201332. e428.","journal-title":"J Allergy Clin Immunol"},{"key":"9452_CR4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","volume":"1","author":"SD Davis","year":"1966","unstructured":"Davis SD, Schaller J, Wedgwood RJ. Job's syndrome. Recurrent, \u201ccold\u201d, staphylococcal abscesses. Lancet. 1966;1:1013\u20135.","journal-title":"Lancet"},{"key":"9452_CR5","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608\u201319.","journal-title":"N Engl J Med"},{"key":"9452_CR6","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058\u201362.","journal-title":"Nature"},{"key":"9452_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","volume":"122","author":"ED Renner","year":"2008","unstructured":"Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122:181\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"9452_CR8","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","volume":"205","author":"CS Ma","year":"2008","unstructured":"Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008;205:1551\u20137.","journal-title":"J Exp Med"},{"key":"9452_CR9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","volume":"452","author":"JD Milner","year":"2008","unstructured":"Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452:773\u20136.","journal-title":"Nature"},{"key":"9452_CR10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.molimm.2008.07.001","volume":"46","author":"H Jiao","year":"2008","unstructured":"Jiao H, Toth B, Erdos M, Fransson I, Rakoczi E, Balogh I, et al. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol. 2008;46:202\u20136.","journal-title":"Mol Immunol"},{"key":"9452_CR11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ACI.0b013e3282f1baea","volume":"7","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Karasuyama H. Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiency. Curr Opin Allergy Clin Immunol. 2007;7:506\u20139.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9452_CR12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2353\/jmoldx.2010.090080","volume":"12","author":"A Kum\u00e1novics","year":"2010","unstructured":"Kum\u00e1novics A, Wittwer CT, Pryor RJ, Augustine NH, Leppert MF, Carey JC, et al. Rapid molecular analysis of the STAT3 gene in Job syndrome of hyper-IgE and recurrent infectious diseases. J Mol Diagn. 2010;12:213\u20139.","journal-title":"J Mol Diagn"},{"key":"9452_CR13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaci.2009.05.004","volume":"124","author":"S Al Khatib","year":"2009","unstructured":"Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H, et al. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol. 2009;124:342\u20138. e341\u2013345.","journal-title":"J Allergy Clin Immunol"},{"key":"9452_CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","volume":"144","author":"ED Renner","year":"2004","unstructured":"Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004;144:93\u20139.","journal-title":"J Pediatr"},{"key":"9452_CR15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","volume":"124","author":"KR Engelhardt","year":"2009","unstructured":"Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:1289\u2013302. e1284.","journal-title":"J Allergy Clin Immunol"},{"key":"9452_CR16","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","volume":"361","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046\u201355.","journal-title":"N Engl J Med"},{"key":"9452_CR17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","volume":"25","author":"Y Minegishi","year":"2006","unstructured":"Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25:745\u201355.","journal-title":"Immunity"},{"key":"9452_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.immuni.2007.05.007","volume":"26","author":"C Woellner","year":"2007","unstructured":"Woellner C, Schaffer AA, Puck JM, Renner ED, Knebel C, Holland SM, et al. The hyper IgE syndrome and mutations in TYK2. Immunity. 2007;26:535. author reply 536.","journal-title":"Immunity"},{"key":"9452_CR19","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1016\/j.leukres.2010.01.024","volume":"34","author":"D Belada","year":"2010","unstructured":"Belada D, Smolej L, Stepankova P, Kralickova P, Freiberger T. Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: successful treatment with risk-adapted rituximab-based immunochemotherapy. Leuk Res. 2010;34:e232\u20134.","journal-title":"Leuk Res"},{"key":"9452_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1607-551X(10)70030-9","volume":"26","author":"CH Chang","year":"2010","unstructured":"Chang CH, Hsu YH. Hyper-IgE syndrome with Epstein\u2013Barr virus associated extranodal NK\/T cell lymphoma of skin. Kaohsiung J Med Sci. 2010;26:206\u201310.","journal-title":"Kaohsiung J Med Sci"},{"key":"9452_CR21","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/1097-0142(197706)39:6<2386::AID-CNCR2820390612>3.0.CO;2-X","volume":"39","author":"JF Bale Jr","year":"1977","unstructured":"Bale Jr JF, Wilson JF, Hill HR. Fatal histiocytic lymphoma of the brain associated with hyperimmunoglobulinemia-E and recurrent infections. Cancer. 1977;39:2386\u201390.","journal-title":"Cancer"},{"key":"9452_CR22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9343(98)00200-9","volume":"105","author":"TA Nester","year":"1998","unstructured":"Nester TA, Wagnon AH, Reilly WF, Spitzer G, Kjeldsberg CR, Hill HR. Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med. 1998;105:162\u20134.","journal-title":"Am J Med"},{"key":"9452_CR23","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1080\/10428190400004463","volume":"45","author":"GD Leonard","year":"2004","unstructured":"Leonard GD, Posadas E, Herrmann PC, Anderson VL, Jaffe ES, Holland SM, et al. Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma. 2004;45:2521\u20135.","journal-title":"Leuk Lymphoma"},{"key":"9452_CR24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1471-0528.1998.tb10137.x","volume":"105","author":"TJ Clark","year":"1998","unstructured":"Clark TJ, Herod JJ, Kehoe S, Luesley DM. The development of invasive vulvar cancer in a patient with Job's syndrome, a rare immunodeficient condition. Br J Obstet Gynaecol. 1998;105:468\u201370.","journal-title":"Br J Obstet Gynaecol"},{"key":"9452_CR25","doi-asserted-by":"crossref","first-page":"13897","DOI":"10.1073\/pnas.94.25.13897","volume":"94","author":"S Takemoto","year":"1997","unstructured":"Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, Matsuoka M, et al. Proliferation of adult T cell leukemia\/lymphoma cells is associated with the constitutive activation of JAK\/STAT proteins. Proc Natl Acad Sci USA. 1997;94:13897\u2013902.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9452_CR26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1171721","volume":"324","author":"DJ Gough","year":"2009","unstructured":"Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science. 2009;324:1713\u20136.","journal-title":"Science"},{"key":"9452_CR27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.1164551","volume":"323","author":"J Wegrzyn","year":"2009","unstructured":"Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, et al. Function of mitochondrial Stat3 in cellular respiration. Science. 2009;323:793\u20137.","journal-title":"Science"},{"key":"9452_CR28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/blood.V98.3.762","volume":"98","author":"D Kube","year":"2001","unstructured":"Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrmann I, et al. STAT3 is constitutively activated in Hodgkin cell lines. Blood. 2001;98:762\u201370.","journal-title":"Blood"},{"key":"9452_CR29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.168.1.466","volume":"168","author":"Q Zhang","year":"2002","unstructured":"Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, et al. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T\/null-cell lymphoma. J Immunol. 2002;168:466\u201374.","journal-title":"J Immunol"},{"key":"9452_CR30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccr.2004.10.020","volume":"6","author":"CS Mitsiades","year":"2004","unstructured":"Mitsiades CS, Mitsiades N, Munshi NC, Anderson KC. Focus on multiple myeloma. Cancer Cell. 2004;6:439\u201344.","journal-title":"Cancer Cell"},{"key":"9452_CR31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm1249","volume":"11","author":"R Chiarle","year":"2005","unstructured":"Chiarle R, Simmons WJ, Cai H, Dhall G, Zamo A, Raz R, et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med. 2005;11:623\u20139.","journal-title":"Nat Med"},{"key":"9452_CR32","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-04-087734","volume":"111","author":"BB Ding","year":"2008","unstructured":"Ding BB, Yu JJ, Yu RY, Mendez LM, Shaknovich R, Zhang Y, et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood. 2008;111:1515\u201323.","journal-title":"Blood"},{"key":"9452_CR33","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood-2007-09-111948","volume":"111","author":"LT Lam","year":"2008","unstructured":"Lam LT, Wright G, Davis RE, Lenz G, Farinha P, Dang L, et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood. 2008;111:3701\u201313.","journal-title":"Blood"},{"key":"9452_CR34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.7541555","volume":"269","author":"CL Yu","year":"1995","unstructured":"Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science. 1995;269:81\u20133.","journal-title":"Science"},{"key":"9452_CR35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","volume":"98","author":"JF Bromberg","year":"1999","unstructured":"Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, et al. Stat3 as an oncogene. Cell. 1999;98:295\u2013303.","journal-title":"Cell"},{"key":"9452_CR36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","volume":"10","author":"R Catlett-Falcone","year":"1999","unstructured":"Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 1999;10:105\u201315.","journal-title":"Immunity"},{"key":"9452_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"H Yu","year":"2004","unstructured":"Yu H, Jove R. The STATs of cancer\u2014new molecular targets come of age. Nat Rev Cancer. 2004;4:97\u2013105.","journal-title":"Nat Rev Cancer"},{"key":"9452_CR38","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","volume":"21","author":"G Niu","year":"2002","unstructured":"Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 2002;21:2000\u20138.","journal-title":"Oncogene"},{"key":"9452_CR39","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI200421032","volume":"114","author":"KS Chan","year":"2004","unstructured":"Chan KS, Sano S, Kiguchi K, Anders J, Komazawa N, Takeda J, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest. 2004;114:720\u20138.","journal-title":"J Clin Invest"},{"key":"9452_CR40","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1073\/pnas.94.13.6764","volume":"94","author":"M Nielsen","year":"1997","unstructured":"Nielsen M, Kaltoft K, Nordahl M, Ropke C, Geisler C, Mustelin T, et al. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci USA. 1997;94:6764\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9452_CR41","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1182\/blood-2005-08-007377","volume":"108","author":"Q Zhang","year":"2006","unstructured":"Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood. 2006;108:1058\u201364.","journal-title":"Blood"},{"key":"9452_CR42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1385\/MO:23:1:141","volume":"23","author":"IK Onal","year":"2006","unstructured":"Onal IK, Kurt M, Altundag K, Aksoy S, Dincer M, Gullu I. Peripheral T-cell lymphoma and Job's syndrome: a rare association. Med Oncol. 2006;23:141\u20134.","journal-title":"Med Oncol"},{"key":"9452_CR43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.febslet.2004.06.095","volume":"572","author":"A Ruusala","year":"2004","unstructured":"Ruusala A, Aspenstrom P. Isolation and characterisation of DOCK8, a member of the DOCK180-related regulators of cell morphology. FEBS Lett. 2004;572:159\u201366.","journal-title":"FEBS Lett"},{"key":"9452_CR44","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/ni.1820","volume":"10","author":"KL Randall","year":"2009","unstructured":"Randall KL, Lambe T, Johnson AL, Treanor B, Kucharska E, Domaschenz H, et al. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nat Immunol. 2009;10:1283\u201391.","journal-title":"Nat Immunol"},{"key":"9452_CR45","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00000372-200012000-00008","volume":"22","author":"JY Lei","year":"2000","unstructured":"Lei JY, Wang Y, Jaffe ES, Turner ML, Raffeld M, Sorbara L, et al. Microcystic adnexal carcinoma associated with primary immunodeficiency, recurrent diffuse herpes simplex virus infection, and cutaneous T-cell lymphoma. Am J Dermatopathol. 2000;22:524\u20139.","journal-title":"Am J Dermatopathol"},{"key":"9452_CR46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-008-9644-z","volume":"90","author":"A Idbaih","year":"2008","unstructured":"Idbaih A, Carvalho Silva R, Criniere E, Marie Y, Carpentier C, Boisselier B, et al. Genomic changes in progression of low-grade gliomas. J Neurooncol. 2008;90:133\u201340.","journal-title":"J Neurooncol"},{"key":"9452_CR47","first-page":"327","volume":"37","author":"JU Kang","year":"2010","unstructured":"Kang JU, Koo SH, Kwon KC, Park JW. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung. Int J Oncol. 2010;37:327\u201335.","journal-title":"Int J Oncol"},{"key":"9452_CR48","first-page":"321","volume":"28","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Kohno T, Ajima R, Sasaki H, Minna JD, Fujiwara T, et al. Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. Int J Oncol. 2006;28:321\u20138.","journal-title":"Int J Oncol"},{"key":"9452_CR49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(03)00155-7","volume":"112","author":"V Yajnik","year":"2003","unstructured":"Yajnik V, Paulding C, Sordella R, McClatchey AI, Saito M, Wahrer DC, et al. DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell. 2003;112:673\u201384.","journal-title":"Cell"},{"key":"9452_CR50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0091-6749(89)90471-5","volume":"83","author":"LJ Gorin","year":"1989","unstructured":"Gorin LJ, Jeha SC, Sullivan MP, Rosenblatt HM, Shearer WT. Burkitt's lymphoma developing in a 7-year-old boy with hyper-IgE syndrome. J Allergy Clin Immunol. 1989;83:5\u201310.","journal-title":"J Allergy Clin Immunol"},{"key":"9452_CR51","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1055\/s-2008-1065133","volume":"115","author":"H Einsele","year":"1990","unstructured":"Einsele H, Saal JG, Dopfer R, Niethammer D, Waller HD, Muller CA. Highly malignant non-Hodgkin's lymphoma in hyper-IgE syndrome. Dtsch Med Wochenschr. 1990;115:1141\u20134.","journal-title":"Dtsch Med Wochenschr"},{"key":"9452_CR52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0037-198X(96)80015-0","volume":"31","author":"RM Kowalchuk","year":"1996","unstructured":"Kowalchuk RM. Case of the season. Job's syndrome with superimposed lymphoma. Semin Roentgenol. 1996;31:254\u20136.","journal-title":"Semin Roentgenol"},{"key":"9452_CR53","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/08880019809016576","volume":"15","author":"SJ Lin","year":"1998","unstructured":"Lin SJ, Huang JL, Hsieh KH. Hodgkin's disease in a child with hyperimmunoglobulin E syndrome. Pediatr Hematol Oncol. 1998;15:451\u20134.","journal-title":"Pediatr Hematol Oncol"},{"key":"9452_CR54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00019048-200009030-00006","volume":"9","author":"KK Huber","year":"2000","unstructured":"Huber KK, Cole KJ, Greene JN, Sandin RL, Vincent AL, Brown R. Malignancies associated with hyper-IgE syndrome: case and review. Infect Dis Clin Practice. 2000;9:128\u201330.","journal-title":"Infect Dis Clin Practice"},{"key":"9452_CR55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1399-3038.2002.00088.x","volume":"13","author":"R Mosseri","year":"2002","unstructured":"Mosseri R, Finkelstein Y, Monselize Y, Garty BZ. Large T-cell lymphoma in a 13-year-old girl with hyperimmunoglobulinemia E syndrome. Pediatr Allergy Immunol. 2002;13:143\u20136.","journal-title":"Pediatr Allergy Immunol"},{"key":"9452_CR56","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1365-4632.2003.01829.x","volume":"42","author":"MW Lee","year":"2003","unstructured":"Lee MW, Choi JH, Sung KJ, Moon KC, Koh JK. Extensive xanthelasma associated with anaplastic large cell lymphoma and hyperimmunoglobulin E syndrome. Int J Dermatol. 2003;42:944\u20136.","journal-title":"Int J Dermatol"},{"key":"9452_CR57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08880010500313512","volume":"23","author":"MA Kashef","year":"2006","unstructured":"Kashef MA, Kashef S, Handjani F, Karimi M. Hodgkin lymphoma developing in a 4.5-year-old girl with hyper-IgE syndrome. Pediatr Hematol Oncol. 2006;23:59\u201363.","journal-title":"Pediatr Hematol Oncol"},{"key":"9452_CR58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3816\/CLM.2007.n.022","volume":"7","author":"N Wallet","year":"2007","unstructured":"Wallet N, Ghez D, Delarue R, Suarez F, Rubio MT, Fischer A, et al. Diffuse large B-cell lymphoma in hyperimmunoglobulinemia E syndrome. Clin Lymphoma Myeloma. 2007;7:425\u20137.","journal-title":"Clin Lymphoma Myeloma"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9452-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-010-9452-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9452-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:10:09Z","timestamp":1559261409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-010-9452-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,22]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["9452"],"URL":"https:\/\/doi.org\/10.1007\/s10875-010-9452-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,22]]}}}